Prevalence of Plasmid-Mediated Quinolone Resistance (PMQR) Determinants Among Extended Spectrum Beta-Lactamases (ESBL)-Producing Isolates of Escherichia coli and Klebsiella pneumoniae in Aleppo, Syria

Authors Information
Article Notes and Dates
To Cite : Alheib O, Al Kayali R, Abajy M Y. Prevalence of Plasmid-Mediated Quinolone Resistance (PMQR) Determinants Among Extended Spectrum Beta-Lactamases (ESBL)-Producing Isolates of Escherichia coli and Klebsiella pneumoniae in Aleppo, Syria, Arch Clin Infect Dis. 2015 ;10(3):e20631. doi: 10.5812/archcid.20631.
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cremet L, Caroff N, Dauvergne S, Reynaud A, Lepelletier D, Corvec S. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Pathol Biol (Paris). 2011; 59(3): 151-6[DOI][PubMed]
  • 2. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10): 629-40[DOI][PubMed]
  • 3. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat. 1999; 2(1): 38-55[DOI][PubMed]
  • 4. Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis. 2000; 31 Suppl 2-8[DOI][PubMed]
  • 5. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22(4): 664-89[DOI][PubMed]
  • 6. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, et al. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother. 2006; 50(4): 1178-82[DOI][PubMed]
  • 7. Cavaco LM, Hasman H, Xia S, Aarestrup FM. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother. 2009; 53(2): 603-8[DOI][PubMed]
  • 8. Jacoby G, Cattoir V, Hooper D, Martinez-Martinez L, Nordmann P, Pascual A, et al. qnr Gene nomenclature. Antimicrob Agents Chemother. 2008; 52(7): 2297-9[DOI][PubMed]
  • 9. Martinez-Martinez L, Eliecer Cano M, Manuel Rodriguez-Martinez J, Calvo J, Pascual A. Plasmid-mediated quinolone resistance. Expert Rev Anti Infect Ther. 2008; 6(5): 685-711[DOI][PubMed]
  • 10. Poirel L, Cattoir V, Nordmann P. Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect. 2008; 14(4): 295-7[DOI][PubMed]
  • 11. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006; 12(1): 83-8[DOI][PubMed]
  • 12. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007; 51(9): 3354-60[DOI][PubMed]
  • 13. Perichon B, Courvalin P, Galimand M. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother. 2007; 51(7): 2464-9[DOI][PubMed]
  • 14. Youssef N, Faris S, AlSubal I. Relationship of ESBL production with fluoroquinolones resistance in Escherichai coli and Klebsiella pneumoniae isolates: The available medications. Research Journal of Aleppo University. 2013; 91(1): 17
  • 15. CLSI. . Clinical and Laboratory Standards Institute; twentieth informational supplement. Performance standards for antimicrobial susceptibility Testing twentieth informational supplement 2010;
  • 16. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006; 50(11): 3953-5[DOI][PubMed]
  • 17. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006; 50(8): 2872-4[DOI][PubMed]
  • 18. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009; 53(2): 639-45[DOI][PubMed]
  • 19. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007; 60(2): 394-7[DOI][PubMed]
  • 20. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother. 2003; 47(2): 559-62[PubMed]
  • 21. Lavilla S, Gonzalez-Lopez JJ, Sabate M, Garcia-Fernandez A, Larrosa MN, Bartolome RM, et al. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. J Antimicrob Chemother. 2008; 61(2): 291-5[DOI][PubMed]
  • 22. Cai X, Li C, Huang J, Li Y. Prevalence of plaasmid-mediated quinolone resistance qnr genes in Central China. African Journal of Microbiology Research. 2011; 5(8): 978
  • 23. Karah N, Poirel L, Bengtsson S, Sundqvist M, Kahlmeter G, Nordmann P, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis. 2010; 66(4): 425-31[DOI][PubMed]
  • 24. Poirel L, Leviandier C, Nordmann P. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital. Antimicrob Agents Chemother. 2006; 50(12): 3992-7[DOI][PubMed]
  • 25. Jiang Y, Zhou Z, Qian Y, Wei Z, Yu Y, Hu S, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother. 2008; 61(5): 1003-6[DOI][PubMed]
  • 26. Rios E, Rodriguez-Avial I, Rodriguez-Avial C, Hernandez E, Picazo JJ. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum beta-lactamase-producing Escherichia coli in Madrid, Spain. Diagn Microbiol Infect Dis. 2010; 67(4): 380-3[DOI][PubMed]
  • 27. Kanamori H, Navarro RB, Yano H, Sombrero LT, Capeding MR, Lupisan SP, et al. Molecular characteristics of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae from the Philippines. Acta Trop. 2011; 120(1-2): 140-5[DOI][PubMed]
  • 28. Nazik H, Ongen B, Kuvat N. Investigation of plasmid-mediated quinolone resistance among isolates obtained in a Turkish intensive care unit. Jpn J Infect Dis. 2008; 61(4): 310-2[PubMed]
  • 29. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother. 2005; 49(1): 71-6[DOI][PubMed]
  • 30. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998; 351(9105): 797-9[DOI][PubMed]
  • 31. Cattoir V, Poirel L, Nordmann P. Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob Agents Chemother. 2008; 52(10): 3801-4[DOI][PubMed]
  • 32. Casin I, Bordon F, Bertin P, Coutrot A, Podglajen I, Brasseur R, et al. Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Antimicrob Agents Chemother. 1998; 42(2): 209-15[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Archives of Clinical Infectious Diseases accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check